For patients with HIV viral load is key in immune response to yellow fever vaccineby Michael Carter, 2012-02-02 08:10
Viral load is the only factor associated
with a poorer antibody response to the yellow fever vaccine in patients with
HIV, according to a French study published in the online edition of the Journal of Acquired Immune Deficiency
Syndromes.
For patients vaccinated after diagnosis
with HIV, an undetectable viral load was the “unique determinant” of
Contraception in HIV prevention trials: injectable hormonal methods more effective?by Carole Leach-Lemens, 2012-02-02 07:10
Women
using injectable (hormonal) contraceptives had a significantly lower rate of
pregnancy compared to those using oral contraception in a major HIV prevention study, researchers report in the advance online edition of AIDS.
However the same study also found that women who used an injectable hormonal contraceptive method were at higher risk of
Men who have sex with men may now be the highest-risk group for HIV in Africa, IAVI study suggestsby Gus Cairns, 2012-02-01 11:30
Men who have sex with men may now be at considerably higher
risk of acquiring HIV than other at-risk groups such as female sex workers or
young people of either sex, if findings by the International AIDS Vaccine
Initiative (IAVI) of HIV incidence at two centres in Kenya can be generalised to other
populations.
The
HIV care providers in US struggling to cope with rising patient numbersby Michael Carter, 2012-02-01 08:40
HIV doctors in the US are struggling to
meet the demands of a rising patient caseload, according to the findings of a
national survey.
Two-thirds of HIV treatment providers
reported an increase in patient numbers, and a third reported difficulties
being reimbursed for the care they provided.
The second annual HealthHIV State of Primary
Quarter of men resume sex before wounds from circumcision fully healed in Zambian studyby Michael Carter, 2012-01-31 09:00
Approximately a quarter of men undergoing circumcision
resume sexual activity before their wounds have fully healed, Zambian research
published in the online edition of AIDS
shows.
Most of the men reporting the early resumption of sexual
activity engaged in unprotected sex, often with multiple partners.
The investigators calculated that early resumption of sexual
activity at this
Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its useby Michael Carter, 2012-01-31 08:10
Raltegravir could have a “useful” role in HIV post-exposure
prophylaxis, according to investigators from the US writing in the online
edition of the Journal of Acquired Immune
Deficiency Syndromes.
Doctors in Boston, Massachusetts, prescribed a post-exposure
prophylaxis (PEP) regimen of raltegravir (Isentress)
with tenofovir and FTC (Truvada) to
100 patients after possible sexual exposure to HIV.
For study participants, PrEP was an opportunity to save their relationshipby Roger Pebody, 2012-01-30 10:00
Seeking to understand why adherence to pre-exposure
prophylaxis (PrEP) was extremely high in a study of serodiscordant couples,
qualitative researchers have found that trial participants saw PrEP as a way
they could preserve their relationship despite the pressures created by the
knowledge of different HIV status and the risk of infection. In an article
published
Majority of HIV-positive patients in US not receiving regular medical careby Michael Carter, 2012-01-30 08:10
Only 45% of
HIV-positive patients in the US are receiving regular medical monitoring,
research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests.
The study also showed
that a third of patients were not being linked with specialist HIV care within
the first year of their diagnosis with the